The new ASAS classification criteria for axial and peripheral spondyloarthritis: Promises and pitfalls

Sarah Lipton, Atulya (Atul) Deodhar

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Spondyloarthritis (SpA), if not diagnosed and treated early, often leads to significant morbidity. Unfortunately, diagnosis and implementation of therapy are frequently delayed, in many cases by years. The Assessment of SpondyloArthritis International Society has recently developed new criteria for classification of both axial and peripheral SpA. The new criteria were formulated with the aim of enhancing design of clinical trials, and ultimately leading to earlier and more effective diagnosis and treatment in the clinical setting. This paper reviews the process of the development of both sets of criteria, and discusses their potential advantages and disadvantages.

Original languageEnglish (US)
Pages (from-to)675-682
Number of pages8
JournalInternational Journal of Clinical Rheumatology
Volume7
Issue number6
DOIs
StatePublished - Dec 2012

Fingerprint

Clinical Trials
Morbidity
Therapeutics

Keywords

  • ankylosing spondylitis
  • axial spondyloarthritis
  • dactylitis
  • enthesitis
  • HLA-B27
  • inflammatory bowel disease-related arthrits
  • psoriatic arthritis
  • reactive arthritis
  • sacroiliitis
  • spondylitis

ASJC Scopus subject areas

  • Rheumatology

Cite this

@article{06764e92bf9b441389d4a72ec1ebfbac,
title = "The new ASAS classification criteria for axial and peripheral spondyloarthritis: Promises and pitfalls",
abstract = "Spondyloarthritis (SpA), if not diagnosed and treated early, often leads to significant morbidity. Unfortunately, diagnosis and implementation of therapy are frequently delayed, in many cases by years. The Assessment of SpondyloArthritis International Society has recently developed new criteria for classification of both axial and peripheral SpA. The new criteria were formulated with the aim of enhancing design of clinical trials, and ultimately leading to earlier and more effective diagnosis and treatment in the clinical setting. This paper reviews the process of the development of both sets of criteria, and discusses their potential advantages and disadvantages.",
keywords = "ankylosing spondylitis, axial spondyloarthritis, dactylitis, enthesitis, HLA-B27, inflammatory bowel disease-related arthrits, psoriatic arthritis, reactive arthritis, sacroiliitis, spondylitis",
author = "Sarah Lipton and Deodhar, {Atulya (Atul)}",
year = "2012",
month = "12",
doi = "10.2217/ijr.12.61",
language = "English (US)",
volume = "7",
pages = "675--682",
journal = "Future Rheumatology",
issn = "1758-4272",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - The new ASAS classification criteria for axial and peripheral spondyloarthritis

T2 - Promises and pitfalls

AU - Lipton, Sarah

AU - Deodhar, Atulya (Atul)

PY - 2012/12

Y1 - 2012/12

N2 - Spondyloarthritis (SpA), if not diagnosed and treated early, often leads to significant morbidity. Unfortunately, diagnosis and implementation of therapy are frequently delayed, in many cases by years. The Assessment of SpondyloArthritis International Society has recently developed new criteria for classification of both axial and peripheral SpA. The new criteria were formulated with the aim of enhancing design of clinical trials, and ultimately leading to earlier and more effective diagnosis and treatment in the clinical setting. This paper reviews the process of the development of both sets of criteria, and discusses their potential advantages and disadvantages.

AB - Spondyloarthritis (SpA), if not diagnosed and treated early, often leads to significant morbidity. Unfortunately, diagnosis and implementation of therapy are frequently delayed, in many cases by years. The Assessment of SpondyloArthritis International Society has recently developed new criteria for classification of both axial and peripheral SpA. The new criteria were formulated with the aim of enhancing design of clinical trials, and ultimately leading to earlier and more effective diagnosis and treatment in the clinical setting. This paper reviews the process of the development of both sets of criteria, and discusses their potential advantages and disadvantages.

KW - ankylosing spondylitis

KW - axial spondyloarthritis

KW - dactylitis

KW - enthesitis

KW - HLA-B27

KW - inflammatory bowel disease-related arthrits

KW - psoriatic arthritis

KW - reactive arthritis

KW - sacroiliitis

KW - spondylitis

UR - http://www.scopus.com/inward/record.url?scp=84870374953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870374953&partnerID=8YFLogxK

U2 - 10.2217/ijr.12.61

DO - 10.2217/ijr.12.61

M3 - Article

AN - SCOPUS:84870374953

VL - 7

SP - 675

EP - 682

JO - Future Rheumatology

JF - Future Rheumatology

SN - 1758-4272

IS - 6

ER -